Poster Session I
Year: 2014
Type: article
Source: Neuropsychopharmacology
DOI: 10.1038/npp.2014.280
Language: English
Subfield: Biological Psychiatry
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Funders: Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Bayer, GlaxoSmithKline, Novartis, Sanofi, Sunovion, National Alliance for Research on Schizophrenia and Depression, Vanda Pharmaceuticals, Jazz Pharmaceuticals, Orexigen Therapeutics, Cerecor, Supernus Pharmaceuticals, American Society of Clinical Psychopharmacology, Belvoir Media Group, Concert Pharmaceuticals, Eisai, Servier, Mitsubishi Tanabe Pharma Corporation, H. Lundbeck A/S, Agency for Healthcare Research and Quality, National Institute of Mental Health, National Institute on Drug Abuse, National Center for Complementary and Alternative Medicine
OpenAlex ID: W4243301368
